JP2002535266A - 細胞保護およびＨ．ｐｙｌｏｒｉ感染の処置のための標的化小胞構築物 - Google Patents

細胞保護およびＨ．ｐｙｌｏｒｉ感染の処置のための標的化小胞構築物

Info

Publication number
JP2002535266A
JP2002535266A JP2000594444A JP2000594444A JP2002535266A JP 2002535266 A JP2002535266 A JP 2002535266A JP 2000594444 A JP2000594444 A JP 2000594444A JP 2000594444 A JP2000594444 A JP 2000594444A JP 2002535266 A JP2002535266 A JP 2002535266A
Authority
JP
Japan
Prior art keywords
composition
liposomes
drug
lectin
phosphatidylcholine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2000594444A
Other languages
English (en)
Japanese (ja)
Inventor
アマージット シン，
ラヘッシュ ジャイン，
Original Assignee
パナセア バイオテック リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by パナセア バイオテック リミテッド filed Critical パナセア バイオテック リミテッド
Publication of JP2002535266A publication Critical patent/JP2002535266A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2000594444A 1999-01-25 2000-01-24 細胞保護およびＨ．ｐｙｌｏｒｉ感染の処置のための標的化小胞構築物 Pending JP2002535266A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN141DE1999 IN190017B (cg-RX-API-DMAC10.html) 1999-01-25 1999-01-25
IN141/DEL/99 1999-01-25
PCT/IN2000/000004 WO2000042987A2 (en) 1999-01-25 2000-01-24 Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections

Publications (1)

Publication Number Publication Date
JP2002535266A true JP2002535266A (ja) 2002-10-22

Family

ID=11088428

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000594444A Pending JP2002535266A (ja) 1999-01-25 2000-01-24 細胞保護およびＨ．ｐｙｌｏｒｉ感染の処置のための標的化小胞構築物

Country Status (8)

Country Link
US (1) US6306838B1 (cg-RX-API-DMAC10.html)
EP (1) EP1105097A2 (cg-RX-API-DMAC10.html)
JP (1) JP2002535266A (cg-RX-API-DMAC10.html)
AU (1) AU3322100A (cg-RX-API-DMAC10.html)
BR (1) BR0004813A (cg-RX-API-DMAC10.html)
IN (1) IN190017B (cg-RX-API-DMAC10.html)
RU (1) RU2207113C2 (cg-RX-API-DMAC10.html)
WO (1) WO2000042987A2 (cg-RX-API-DMAC10.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE432691T1 (de) * 2000-03-28 2009-06-15 Sandoz Ag Geschmackmaskierte granulierte teilchen
US6576625B2 (en) * 2001-03-16 2003-06-10 Panacea Biotic Limited Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
EP1350507A1 (en) * 2002-04-04 2003-10-08 Applied NanoSystems B.V. Delivery of a substance to a pre-determinated site
JP4926707B2 (ja) 2003-08-22 2012-05-09 ダニスコ エイ／エス 封入化抗菌材料
RU2378830C2 (ru) * 2003-08-22 2010-01-20 Даниско А/С Инкапсулированный антимикробный материал
GB2388581A (en) 2003-08-22 2003-11-19 Danisco Coated aqueous beads
WO2006015423A1 (en) * 2004-08-11 2006-02-16 Clifford C Holloway Method and apparatus for collection and treatment of encapsulated waste
RU2320323C1 (ru) * 2006-08-03 2008-03-27 Игорь Александрович Базиков Система доставки биологически активных веществ с помощью ниосом
US20180177725A1 (en) * 2015-09-10 2018-06-28 Washington State University Cell membrane-formed nanoscale vesicles and methods of using thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9010039D0 (en) * 1990-05-03 1990-06-27 Reckitt & Colmann Prod Ltd Medicament preparation
AU652778B2 (en) * 1990-10-15 1994-09-08 Quest International B.V. Treatment composition
US5478819A (en) * 1993-06-23 1995-12-26 Simo Tarpila Phospholipid composition and use thereof
EP0676199B1 (en) 1994-04-07 1998-09-02 Pfizer Inc. Use of trovafloxacin or derivatives thereof for the manufacture of a medicament for the treatment of H. pylori infections
GB9407869D0 (en) 1994-04-20 1994-06-15 Caduceus Ltd Antimicrobial compounds
FR2718965B1 (fr) 1994-04-25 1996-05-24 Rhone Poulenc Rorer Sa Nouvelle application thérapeutique de la spiramycine.
AU6580494A (en) 1994-05-11 1995-12-05 P.N. Gerolymatos S.A. Use of clioquinol for treating helicobacter, including (h. pylori), infections and related diseases
GB9505032D0 (en) * 1995-03-13 1995-05-03 Westminster Lab Ltd Improvements in or relating to organic compositions
AU4596796A (en) 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with bismuth and antibacterials
WO1996024368A1 (en) * 1995-02-07 1996-08-15 Lectin Biopharma, Inc. Method of using lectins for prevention and treatment of oral and alimentary tract disorders

Also Published As

Publication number Publication date
RU2207113C2 (ru) 2003-06-27
US6306838B1 (en) 2001-10-23
WO2000042987A2 (en) 2000-07-27
BR0004813A (pt) 2000-11-21
EP1105097A2 (en) 2001-06-13
WO2000042987A3 (en) 2000-11-02
WO2000042987A8 (en) 2001-06-28
AU3322100A (en) 2000-08-07
IN190017B (cg-RX-API-DMAC10.html) 2003-05-31

Similar Documents

Publication Publication Date Title
JP4524071B2 (ja) Ｓｎ−３８脂質複合体及び使用方法
KR100317751B1 (ko) 합성미립벡터및그제조방법
EP0260811B1 (en) Phospholipid particles encapsulating polyene antibiotics for the treatment of systemic fungal infections
CN109689104A (zh) α和γ-D聚谷氨酸化抗叶酸剂及其用途
AU2002246510A1 (en) SN-38 lipid complexes and methods of use
JPH069336A (ja) 化粧品組成物
JPH10501534A (ja) 強化されたドラッグ・デリバリーのためのスフィンゴソーム
CN112402379B (zh) 一种仿生外泌体及其制备和应用
EP0481701B1 (en) Treatment composition
JPH03500650A (ja) ポリエン系マクロライドのプレリポソーム粉末
EP1655022A1 (en) Remedy or diagnostic for inflammatory disease containing target-directing liposome
CN106456546A (zh) 用于黏膜递送的脂质体组合物
JP6770524B2 (ja) コクリエート、及び薬理活性物質の組織透過性を高めるためにそれを使用する方法
Hu et al. Liposomes in drug delivery: status and advances
RU2207113C2 (ru) Целевые везикулярные конструкции для защиты клетки и для лечения инфекций h. pylori
US6576625B2 (en) Targeted vesicular constructs for cytoprotection and treatment of H. pylori infections
ES3058285T3 (en) Pharmaceutical compositions with reduced side effect and methods of using the same
JPWO2005021012A1 (ja) ゲムシタビン封入薬剤担体
CN1822844B (zh) 含配糖物的脂质体
WO2014034669A1 (ja) 非極性溶媒に分散性を有する細菌菌体成分を内封する脂質膜構造体およびその製造方法
AU2020295730B2 (en) Liposomal doxorubicin formulation, method for producing a liposomal doxorubicin formulation and use of a liposomal doxorubicin formulation as a medicament
CA2053346C (en) Microcapsule compositions for torical treatment
JP3882034B2 (ja) 腸管吸収制御性リポソーム
JP4590519B2 (ja) 腸管吸収制御性リポソーム
CN105749291B (zh) 一种转移消失蛋白脂质体复合物及其制备方法和应用

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050106